Intravitreal administration of bevacizumab: pros and cons

Daru. 2015 Apr 21;23(1):27. doi: 10.1186/s40199-015-0110-0.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Angiogenesis Inhibitors / administration & dosage*
  • Bevacizumab / administration & dosage*
  • Drug Compounding
  • Drug Stability
  • Humans
  • Intravitreal Injections

Substances

  • Angiogenesis Inhibitors
  • Bevacizumab